Mirae Asset Global ETFs Holdings
ACRS icon

Mirae Asset Global ETFs Holdings’s Aclaris Therapeutics ACRS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Buy
54,578
+10,989
+25% +$49K ﹤0.01% 2308
2026
Q1 		$163K Buy
43,589
+1,021
+2% +$3.44K ﹤0.01% 2455
2025
Q4 		$128K Sell
42,568
-187
-0.4% -$472 ﹤0.01% 2561
2025
Q3 		$81.2K Sell
42,755
-6,867
-14% -$12K ﹤0.01% 2756
2025
Q2 		$70.5K Buy
+49,622
New +$67.1K ﹤0.01% 2769
2024
Q3 		– Sell
-35,794
Closed -$39.4K – 3071
2024
Q2 		$39.4K Buy
+35,794
New +$42.1K ﹤0.01% 2839

Other funds holding ACRS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ACRS Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Aclaris Therapeutics (ACRS) stake by 25% in Q2 2026, buying an estimated $49K and bringing the position to 54,578 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #2308.

Mirae Asset Global ETFs Holdings first reported a position in ACRS in Q2 2024 and has held it in 6 quarters since. 148 funds tracked by Wall St. Rank hold ACRS as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 54,578 shares of Aclaris Therapeutics worth $289K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 10,989 Aclaris Therapeutics shares in Q2 2026, an estimated $49K.
  • Aclaris Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2308 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Aclaris Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • 148 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.